News | Radiation Therapy | August 11, 2015

Cuts for 2016 would reduce physician payments to radiation oncology 5-7 percent or possibly more for community-based centers

ASTRO, Richard Burr, Debbie Stabenow, Medicare, proposed cuts, radiation oncology, MPFS, 2016

August 11, 2015 — The American Society for Radiation Oncology (ASTRO) released a statement applauding U.S. Sens. Richard Burr (R-N.C.) and Debbie Stabenow (D-Mich.) for their efforts to stop proposed Medicare payment cuts to radiation oncology cancer care.

Sens. Burr and Stabenow are asking their Senate colleagues for bipartisan support to tell the Centers for Medicare and Medicaid Services (CMS) to reconsider their proposed cuts to radiation oncology in the recently issued Medicare Physician Fee Schedule (MPFS) for 2016.

The proposed 2016 MPFS recommends reducing physician payments to radiation oncology, including cuts of about 5-7 percent to community-based cancer clinics—potentially higher for some centers depending on their patient populations. In their letter, the two Senators expressed “serious concern” that these cuts will have a significant impact on community-based centers and those that serve patients in rural areas, especially given that these same centers had payment reductions totaling nearly 20 percent during the last six years.

ASTRO will submit comments and recommendations in a letter to CMS by Sept. 8, 2015. 

The most significant portion of the cuts is due to an abrupt change in several policies, including setting values for newly created and revised radiation treatment delivery codes; increasing the assumed equipment utilization rate for linear accelerators used in cancer treatment; and removing the costs associated with several essential direct practice expense inputs, most notably on-board imaging, which ensures safe and accurate radiation treatments.

For more information: www.astro.org


Related Content

News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
Subscribe Now